109
Views
9
CrossRef citations to date
0
Altmetric
Research Article

Design and evaluation of mucoadhesive beads of glipizide as a controlled release drug delivery system

, , &
Pages 220-229 | Received 14 Jan 2013, Accepted 05 Aug 2013, Published online: 19 Sep 2013
 

Abstract

The present work aims at the development of a low-cost controlled release system of glipizide beads embedded in pectin to overcome the problem of frequent dosing of drug. The method of preparation has been optimised by experimental design to achieve satisfactory responses with respect to controlling variables. The controlling variables are X1, drug–polymer ratio; X2, surfactant concentration and X3, isooctane–acetone ratio. The most effective combination is X1(1:6), X2(1%), X3(50:50). Various parameters such as mucoadhesivity and swellability of beads, characterisation, dissolution, stability, ex vivo absorption and in vivo (Oral glucose tolerance test in rat) studies were performed with the optimised product. The optimised product was found quiet satisfactory that showed yield of 86.78%, drug entrapment efficiency (DEE) of 87.38% and drug release was extended up to 18 h. The present formulation of glipizide is a promising multiparticulate system of glipizide with significant hypoglycemic effect, and moreover it was prepared rapidly with ease.

Acknowledgements

The authors acknowledge the cooperation provided by “Calcutta Institute of Pharmaceutical Technology & AHS”, Uluberia, West Bengal, India. The authors are thankful to Mr N. Gani who helped in making of the manuscript.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.